{"rows":[{"id":5862,"title":"Efficacy and Safety of Psychedelic Microdosing on Psychological Outcomes in Healthy Adults: A Systematic Review and Meta-analysis.","authors":"Meshkat S, Leung M, Meshkat S, Lin Q, Wijendran D, Reichelt AC, Zhang Y, Burback L, Winkler O, Greenshaw A, Monson CM, Vermetten E, Jetly R, Lou W, Zeifman RJ, Bhat V","journal":"CNS drugs","publication_date":"2026-10-01","publication_year":2026,"doi":"10.1007/s40263-026-01325-5","pubmed_id":"42593636","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/42593636/","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Brain Imaging,Microdosing,Personality Change,Creativity,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Observational Study,Safety,Adverse Events","study_type":"Randomized Controlled Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-08-15 01:20:04","last_checked":"2026-10-08 01:20:08","bibtex":null,"source_record_id":"PMID:42593636","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/42593636/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:42593636","source_url":"https://pubmed.ncbi.nlm.nih.gov/42593636/","doi":"10.1007/s40263-026-01325-5","pmid":"42593636","publication_date":"2026-10-01","importer_version":"2.1.3","text_redistributed":false}},{"id":5781,"title":"Impact of Psilocybin on Motor Function in Healthy Participants: A Phase 1, Randomised, Triple-Blind, Dose-Finding Study.","authors":"Bhagavan C, Carter O, Nielsen G, Berlowitz D, Issak S, Braat S, Zaloumis S, Attard Z, Oliver G, Mayne D, Rucker J, Butler M, Dandash O, Bryson A, Kanaan RA.","journal":"CNS drugs","publication_date":"2026-08-07","publication_year":2026,"doi":"10.1007/s40263-026-01326-4","pubmed_id":"42566154","openalex_id":"https://openalex.org/W7201866252","source_url":"https://doi.org/10.1007/s40263-026-01326-4","substance_tags":"psilocybin","topic_tags":"Headache / Migraine,Consciousness,Clinical Trial,Healthy Volunteers,Safety,Adverse Events","study_type":"Clinical Trial","source_name":"Europe PMC","publication_status":"published","date_added":"2026-08-08 01:20:06","last_checked":"2026-08-14 01:20:19","bibtex":null,"source_record_id":"PMID:42566154","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.1007/s40263-026-01326-4","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42566154","source_url":"https://doi.org/10.1007/s40263-026-01326-4","doi":"10.1007/s40263-026-01326-4","pmid":"42566154","publication_date":"2026-08-07","importer_version":"2.1.3","text_redistributed":false}},{"id":2249,"title":"Psychedelic Treatments for Psychiatric Disorders: A Systematic Review and Thematic Synthesis of Patient Experiences in Qualitative Studies.","authors":"Breeksema JJ, Niemeijer AR, Krediet E, Vermetten E, Schoevers RA","journal":"CNS drugs","publication_date":"2020-09-01","publication_year":2020,"doi":"10.1007/s40263-020-00748-y","pubmed_id":"32803732","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/32803732/","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,PTSD,Addiction,Eating Disorders,Pharmacology,Emotional Processing,Systematic Review,Review Article","study_type":"Systematic Review","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:24","bibtex":null,"source_record_id":"PMID:32803732","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/32803732/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:32803732","source_url":"https://pubmed.ncbi.nlm.nih.gov/32803732/","doi":"10.1007/s40263-020-00748-y","pmid":"32803732","publication_date":"2020-09-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1858,"title":"Molecular Mechanisms of Psilocybin and Implications for the Treatment of Depression.","authors":"Ling S, Ceban F, Lui LMW, Lee Y, Teopiz KM, Rodrigues NB, Lipsitz O, Gill H, Subramaniapillai M, Mansur RB, Lin K, Ho R, Rosenblat JD, Castle D, McIntyre RS","journal":"CNS drugs","publication_date":"2022-01-01","publication_year":2022,"doi":"10.1007/s40263-021-00877-y","pubmed_id":"34791625","openalex_id":"https://openalex.org/W3213007658","source_url":"https://pubmed.ncbi.nlm.nih.gov/34791625/","substance_tags":"psilocybin","topic_tags":"Depression,Pharmacology,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Review Article,Treatment-Resistant Depression","study_type":"Review Article","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:21","bibtex":null,"source_record_id":"PMID:34791625","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/34791625/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:34791625","source_url":"https://pubmed.ncbi.nlm.nih.gov/34791625/","doi":"10.1007/s40263-021-00877-y","pmid":"34791625","publication_date":"2022-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1675,"title":"A Research Domain Criteria (RDoC)-Guided Dashboard to Review Psilocybin Target Domains: A Systematic Review.","authors":"Pouyan N, Halvaei Khankahdani Z, Younesi Sisi F, Lee Y, Rosenblat JD, Teopiz KM, Lui LMW, Subramaniapillai M, Lin K, Nasri F, Rodrigues N, Gill H, Lipsitz O, Cao B, Ho R, Castle D, McIntyre RS","journal":"CNS drugs","publication_date":"2022-10-01","publication_year":2022,"doi":"10.1007/s40263-022-00944-y","pubmed_id":"36097251","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/36097251/","substance_tags":"psilocybin","topic_tags":"Randomized Controlled Trial,Systematic Review,Review Article","study_type":"Randomized Controlled Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:19","bibtex":null,"source_record_id":"PMID:36097251","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/36097251/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:36097251","source_url":"https://pubmed.ncbi.nlm.nih.gov/36097251/","doi":"10.1007/s40263-022-00944-y","pmid":"36097251","publication_date":"2022-10-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1008,"title":"Current Perspectives on the Clinical Research and Medicalization of Psychedelic Drugs for Addiction Treatments: Safety, Efficacy, Limitations and Challenges.","authors":"Gomez-Escolar A, Folch-Sanchez D, Stefaniuk J, Swithenbank Z, Nisa A, Braddick F, Idrees Chaudhary N, van der Meer PB, Batalla A","journal":"CNS drugs","publication_date":"2024-10-01","publication_year":2024,"doi":"10.1007/s40263-024-01101-3","pubmed_id":"39033264","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/39033264/","substance_tags":"psilocybin","topic_tags":"Depression,PTSD,Addiction,Review Article,Safety","study_type":"Review Article","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:06","bibtex":null,"source_record_id":"PMID:39033264","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/39033264/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:39033264","source_url":"https://pubmed.ncbi.nlm.nih.gov/39033264/","doi":"10.1007/s40263-024-01101-3","pmid":"39033264","publication_date":"2024-10-01","importer_version":"2.1.3","text_redistributed":false}},{"id":538,"title":"Psychedelics for Alcohol Use Disorder: A Narrative Review with Candidate Mechanisms of Action.","authors":"Miller EA, Capone C, Eaton E, Swift RM, Haass-Koffler CL","journal":"CNS drugs","publication_date":"2025-09-01","publication_year":2025,"doi":"10.1007/s40263-025-01199-z","pubmed_id":"40640527","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/40640527/","substance_tags":"psilocybin","topic_tags":"Addiction,Neuroplasticity,Mechanism of Action,Clinical Trial,Review Article,Observational Study","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:27:57","bibtex":null,"source_record_id":"PMID:40640527","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/40640527/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:40640527","source_url":"https://pubmed.ncbi.nlm.nih.gov/40640527/","doi":"10.1007/s40263-025-01199-z","pmid":"40640527","publication_date":"2025-09-01","importer_version":"2.1.3","text_redistributed":false}},{"id":298,"title":"Approved and Pipeline Pharmacological Interventions for Eating Disorders (2010-2025): 15 Years of Progress (or Lack Thereof).","authors":"Hirsch D, Reed J, Naqvi A, Ngor A, Dugan L, Costa K, Ganasi RS, Truman K, Danovitch I, IsHak WW, Hedrick R","journal":"CNS drugs","publication_date":"2026-02-01","publication_year":2026,"doi":"10.1007/s40263-025-01248-7","pubmed_id":"41313392","openalex_id":"https://openalex.org/W4416780344","source_url":"https://pubmed.ncbi.nlm.nih.gov/41313392/","substance_tags":"psilocybin","topic_tags":"Anxiety,OCD,Eating Disorders,Pharmacology,Clinical Trial,Systematic Review,Review Article","study_type":"Systematic Review","source_name":"PubMed","publication_status":"published","date_added":"2026-06-30 22:38:07","last_checked":"2026-08-09 08:27:52","bibtex":null,"source_record_id":"PMID:41313392","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/41313392/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:41313392","source_url":"https://pubmed.ncbi.nlm.nih.gov/41313392/","doi":"10.1007/s40263-025-01248-7","pmid":"41313392","publication_date":"2026-02-01","importer_version":"2.1.3","text_redistributed":false}},{"id":291,"title":"Psilocybin and Bipolar Depression: Promise and Prudence.","authors":"Marques MG, Patarroyo-Rodriguez L, Singh B","journal":"CNS drugs","publication_date":"2026-02-01","publication_year":2026,"doi":"10.1007/s40263-025-01255-8","pubmed_id":"41485178","openalex_id":"https://openalex.org/W7118127068","source_url":"https://pubmed.ncbi.nlm.nih.gov/41485178/","substance_tags":"psilocybin","topic_tags":"Depression,Pharmacology,Aging,Clinical Trial,Safety,Drug Interactions","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-06-30 22:38:07","last_checked":"2026-08-09 08:27:52","bibtex":null,"source_record_id":"PMID:41485178","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/41485178/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:41485178","source_url":"https://pubmed.ncbi.nlm.nih.gov/41485178/","doi":"10.1007/s40263-025-01255-8","pmid":"41485178","publication_date":"2026-02-01","importer_version":"2.1.3","text_redistributed":false}},{"id":252,"title":"Safety and Efficacy of Monoamine Oxidase Inhibitors in Patients Who Use Psychoactive Substances: Potential Drug Interactions and Substance Use Disorder Treatment Data.","authors":"Rached G, Campana A, Fiani D, Nguyen C, Van den Eynde V, Gillman PK, Barnett BS","journal":"CNS drugs","publication_date":"2026-03-01","publication_year":2026,"doi":"10.1007/s40263-025-01256-7","pubmed_id":"41546846","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/41546846/","substance_tags":"psilocybin","topic_tags":"Depression,Addiction,Pharmacology,Receptor Pharmacology,Review Article,Safety,Toxicity,Drug Interactions","study_type":"Review Article","source_name":"PubMed","publication_status":"published","date_added":"2026-06-30 22:38:07","last_checked":"2026-08-09 08:27:52","bibtex":null,"source_record_id":"PMID:41546846","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/41546846/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:41546846","source_url":"https://pubmed.ncbi.nlm.nih.gov/41546846/","doi":"10.1007/s40263-025-01256-7","pmid":"41546846","publication_date":"2026-03-01","importer_version":"2.1.3","text_redistributed":false}},{"id":129,"title":"Pharmacotherapy in Disorders of Consciousness: A Mechanism-Based Review.","authors":"Gillet A, Geron C, Vitello MM, Lejeune N","journal":"CNS drugs","publication_date":"2026-05-01","publication_year":2026,"doi":"10.1007/s40263-026-01274-z","pubmed_id":"41876835","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/41876835/","substance_tags":"psilocin","topic_tags":"Addiction,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Consciousness,Biomarkers,Aging,Review Article,Safety","study_type":"Review Article","source_name":"PubMed","publication_status":"published","date_added":"2026-06-30 22:38:07","last_checked":"2026-08-09 08:27:50","bibtex":null,"source_record_id":"PMID:41876835","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/41876835/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:41876835","source_url":"https://pubmed.ncbi.nlm.nih.gov/41876835/","doi":"10.1007/s40263-026-01274-z","pmid":"41876835","publication_date":"2026-05-01","importer_version":"2.1.3","text_redistributed":false}}],"total":11,"page":1,"per_page":20,"pages":1,"resource":"papers","filters":{"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":"CNS drugs","from":null,"to":null,"added_from":null,"added_to":null,"sort":"newly_added","page":1,"per_page":"20"}}